Fundraising FoxBrainsGate
14 known investors
Find your way into BrainsGate
Sign up to find every way you can get introduced to BrainsGate
- Your email: who you already know at BrainsGate, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the BrainsGate team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
BrainsGate develops a neurostimulation therapy for stroke patients based on stimulation of the sphenopalatine ganglion (SPG) to increase cerebral blood flow. The company operates in the medical device field, having conducted the ImpACT-24 clinical studies for acute ischemic stroke treatment.
Investors · 14
How we know: funding news · biospace.com · Not right? Tell us
How we know: calcalistech.com · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · calcalistech.com · Not right? Tell us
Also in the syndicate · 8
Funding
SEC filings, press & company announcements$14M disclosed across 1 of 3 rounds · 2008–2020
- $14MraisedDec 2020 · 3 sources
BNP Joint Capital Fund (lead), SPERO (lead), Agate, Cipio, Elron, Medtronic, Pitango
Source ↗ - Undisclosed amountseries FDec 2020
BNP (lead), SPERO (lead), Agate, Cipio, Elron, Medtronic, Pitango
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does BrainsGate do?
- BrainsGate develops a neurostimulation therapy for stroke patients based on stimulation of the sphenopalatine ganglion (SPG) to increase cerebral blood flow. The company operates in the medical device field, having conducted the ImpACT-24 clinical studies for acute ischemic stroke treatment.
- Who are BrainsGate's investors?
- BrainsGate's investors include Agate Medical Investments LP, Cipio Partners, Elron Ventures, JJDC, Pitango, Spero Ventures.
- How much funding has BrainsGate raised?
- BrainsGate has disclosed $14M raised across 1 of its 3 known rounds.